Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Pain, Postoperative 3Pain 2Lung Neoplasms 2Colonic Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Spondylitis, Ankylosing 1Pituitary Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Mucositis 1Lymphoma, Follicular 1Inflammation 1Endometrial Neoplasms 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Anastomotic Leak 1Adenocarcinoma of Lung 1Acute Pain 1

Interventions

Etanercept 12Adalimumab 12Infliximab 7golimumab 4Tumor Necrosis Factor Inhibitors 4Certolizumab Pegol 4Abatacept 4tofacitinib 2tocilizumab 2Rituximab 2Antirheumatic Agents 2Vitamin D 1Vaccines 1Syringes 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Saline Solution 1Radioimmunodetection 1Prednisone 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Nivolumab 1Methotrexate 1Methods 1Lysine Acetyltransferase 5 1Licensure 1Leflunomide 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Arthritis, Rheumatoid × Anti-Inflammatory Agents, Non-Steroidal × Clear all
NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡